...
首页> 外文期刊>Journal of Clinical Pharmacy and Therapeutics >Clinically relevant drug‐drug interactions and the risk for drug adverse effects among home‐dwelling older persons with and without type 2 diabetes
【24h】

Clinically relevant drug‐drug interactions and the risk for drug adverse effects among home‐dwelling older persons with and without type 2 diabetes

机译:临床相关的药物 - 药物相互作用以及家居患者患者的药物不良反应风险,没有2型糖尿病

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract What is known and objective Polypharmacy and age are known to increase the risk for potential drug interactions. Type 2 diabetes has been associated with polypharmacy and several comorbidities. Currently, there is no information on whether the frequency of clinically relevant drug‐drug interactions and the risk for drug adverse effects differ between older persons with and without diabetes. The aim of this study was to investigate the frequency of drug‐drug interactions and the risk for drug adverse effects in these two groups in primary care. Methods The basic study population consisted of Finnish home‐dwelling primary care patients aged?≥?65?years (N?=?3039). For each person with diabetes, two controls were selected with adjusted age and gender. To collect data, electronic primary care patient records, a structured health questionnaire and a structured health examination conducted by a physician were utilized. Using the SFINX‐PHARAO ? database, drug‐drug interactions and the risk for drug adverse effects were evaluated in 182 persons with type 2 diabetes and 176 persons without diabetes. Results and discussion There were no significant differences in the frequency of drug‐drug interactions or the risk for drug adverse effects in persons with and without diabetes. At least one clinically relevant interaction was found in 81 (44.5%) persons with diabetes and 73 (41.5%) persons without diabetes. The most common drugs causing interactions included non‐steroidal anti‐inflammatory drugs (NSAIDs) and warfarin. What is new and conclusion There is no difference in the frequency of drug‐drug interactions or risk for drug adverse effects in older home‐dwelling persons with and without diabetes. Due to common comorbidities and commonly used drugs among persons with diabetes, drug‐drug interactions involving warfarin or NSAIDs in particular should be carefully monitored to avoid drug adverse effects.
机译:摘要已知有什么已知的和客观的多药物和年龄可以增加潜在药物相互作用的风险。 2型糖尿病已经与多药物和几种合并症有关。目前,没有关于临床相关药物 - 药物相互作用的频率和药物不良反应风险的信息是否不同于患有糖尿病和没有糖尿病的老年人之间的差异。本研究的目的是研究药物 - 药物相互作用的频率和初级保健中这两组中药物不良反应的风险。方法基础研究人口包括芬兰家居级护理患者?≥?65?年(n?= 3039)。对于患有糖尿病的人,用调整后的年龄和性别选择了两种对照。要收集数据,电子初级保健患者记录,有组织的健康问卷和由医生进行的结构化健康检查。使用sfinx-pharao?在182名糖尿病和176名没有糖尿病的176名没有糖尿病中,评估了数据库,药物 - 药物相互作用和药物不良反应的风险。结果与讨论在药物 - 药物相互作用的频率或患有糖尿病的人的药物不良反应的风险没有显着差异。在81名(44.5%)患有糖尿病的81名(44.5%)和73名没有糖尿病的人的人中,至少发现了至少一个临床相关的相互作用。导致相互作用的最常见的药物包括非甾体类抗炎药(NSAIDs)和Warfarin。什么是新的和结论在较老的家居住宅患者和没有糖尿病的人中药物 - 药物相互作用的频率或药物不良反应风险没有差异。由于糖尿病患者常见的同血症和常用药物,应仔细监测涉及华法林或NSAID的药物 - 药物相互作用,以避免药物不利影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号